Haemonetics ROE 2012-2025 | HAE
Current and historical return on equity (ROE) values for Haemonetics (HAE) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Haemonetics ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-12-31 | $0.18B | $0.91B | 20.33% |
| 2025-09-30 | $0.17B | $0.85B | 19.43% |
| 2025-06-30 | $0.16B | $0.88B | 18.69% |
| 2025-03-31 | $0.17B | $0.82B | 19.02% |
| 2024-12-31 | $0.13B | $0.91B | 14.13% |
| 2024-09-30 | $0.12B | $0.88B | 13.34% |
| 2024-06-30 | $0.11B | $0.91B | 12.32% |
| 2024-03-31 | $0.12B | $0.96B | 12.78% |
| 2023-12-31 | $0.13B | $0.94B | 14.32% |
| 2023-09-30 | $0.13B | $0.89B | 15.27% |
| 2023-06-30 | $0.14B | $0.87B | 17.06% |
| 2023-03-31 | $0.12B | $0.82B | 14.87% |
| 2022-12-31 | $0.10B | $0.78B | 12.70% |
| 2022-09-30 | $0.09B | $0.73B | 11.55% |
| 2022-06-30 | $0.07B | $0.77B | 9.22% |
| 2022-03-31 | $0.04B | $0.75B | 6.16% |
| 2021-12-31 | $0.02B | $0.73B | 3.24% |
| 2021-09-30 | $0.03B | $0.70B | 4.53% |
| 2021-06-30 | $0.07B | $0.68B | 9.30% |
| 2021-03-31 | $0.08B | $0.73B | 11.73% |
| 2020-12-31 | $0.11B | $0.72B | 16.88% |
| 2020-09-30 | $0.11B | $0.67B | 17.55% |
| 2020-06-30 | $0.10B | $0.61B | 16.31% |
| 2020-03-31 | $0.08B | $0.59B | 13.18% |
| 2019-12-31 | $0.08B | $0.58B | 13.23% |
| 2019-09-30 | $0.07B | $0.58B | 10.94% |
| 2019-06-30 | $0.05B | $0.59B | 7.68% |
| 2019-03-31 | $0.06B | $0.67B | 8.19% |
| 2018-12-31 | $0.05B | $0.64B | 6.64% |
| 2018-09-30 | $0.02B | $0.70B | 2.85% |
| 2018-06-30 | $0.02B | $0.67B | 2.89% |
| 2018-03-31 | $0.05B | $0.75B | 5.72% |
| 2017-12-31 | $-0.02B | $0.82B | -2.30% |
| 2017-09-30 | $0.00B | $0.80B | 0.52% |
| 2017-06-30 | $0.00B | $0.77B | 0.53% |
| 2017-03-31 | $-0.03B | $0.74B | -3.49% |
| 2016-12-31 | $0.02B | $0.77B | 2.16% |
| 2016-09-30 | $-0.06B | $0.75B | -7.98% |
| 2016-06-30 | $-0.07B | $0.72B | -8.86% |
| 2016-03-31 | $-0.06B | $0.72B | -7.31% |
| 2015-12-31 | $-0.05B | $0.72B | -6.29% |
| 2015-09-30 | $0.03B | $0.78B | 3.22% |
| 2015-06-30 | $0.02B | $0.79B | 2.44% |
| 2015-03-31 | $0.02B | $0.83B | 1.94% |
| 2014-12-31 | $0.03B | $0.83B | 3.51% |
| 2014-09-30 | $0.03B | $0.82B | 3.52% |
| 2014-06-30 | $0.04B | $0.82B | 4.76% |
| 2014-03-31 | $0.04B | $0.84B | 4.33% |
| 2013-12-31 | $0.04B | $0.83B | 4.80% |
| 2013-09-30 | $0.03B | $0.80B | 4.11% |
| 2013-06-30 | $0.02B | $0.77B | 2.84% |
| 2013-03-31 | $0.04B | $0.77B | 5.20% |
| 2012-12-31 | $0.05B | $0.78B | 5.92% |
| 2012-09-30 | $0.05B | $0.77B | 7.15% |
| 2012-06-30 | $0.06B | $0.76B | 8.35% |
| 2012-03-31 | $0.07B | $0.73B | 9.48% |
| 2011-12-31 | $0.07B | $0.71B | 10.07% |
| 2011-09-30 | $0.07B | $0.68B | 10.57% |
| 2011-06-30 | $0.08B | $0.71B | 11.97% |
| 2011-03-31 | $0.08B | $0.69B | 12.83% |
| 2010-12-31 | $0.06B | $0.65B | 10.50% |
| 2010-09-30 | $0.06B | $0.59B | 10.49% |
| 2010-06-30 | $0.06B | $0.57B | 10.04% |
| 2010-03-31 | $0.06B | $0.59B | 10.05% |
| 2009-12-31 | $0.07B | $0.57B | 12.06% |
| 2009-09-30 | $0.07B | $0.58B | 12.01% |
| 2009-06-30 | $0.06B | $0.56B | 11.90% |
| 2009-03-31 | $0.06B | $0.54B | 11.53% |
| 2008-12-31 | $0.06B | $0.52B | 11.79% |
| 2008-09-30 | $0.06B | $0.50B | 11.64% |
| 2008-06-30 | $0.05B | $0.49B | 11.10% |
| 2008-03-31 | $0.05B | $0.49B | 10.99% |
| 2007-12-31 | $0.06B | $0.47B | 12.35% |
| 2007-09-30 | $0.06B | $0.45B | 13.13% |
| 2007-06-30 | $0.05B | $0.48B | 10.93% |
| 2007-03-31 | $0.05B | $0.48B | 10.58% |
| 2006-12-31 | $0.05B | $0.45B | 10.15% |
| 2006-09-30 | $0.06B | $0.46B | 12.82% |
| 2006-06-30 | $0.07B | $0.46B | 15.68% |
| 2006-03-31 | $0.07B | $0.44B | 17.04% |
| 2005-12-31 | $0.06B | $0.42B | 16.17% |
| 2005-09-30 | $0.05B | $0.39B | 12.41% |
| 2005-06-30 | $0.04B | $0.37B | 12.52% |
| 2005-03-31 | $0.04B | $0.36B | 12.35% |
| 2004-12-31 | $0.04B | $0.34B | 13.10% |
| 2004-09-30 | $0.04B | $0.31B | 13.23% |
| 2004-06-30 | $0.03B | $0.30B | 12.60% |
| 2004-03-31 | $0.03B | $0.28B | 11.42% |
| 2003-12-31 | $0.02B | $0.26B | 9.59% |
| 2003-09-30 | $0.02B | $0.24B | 10.48% |
| 2003-06-30 | $0.03B | $0.23B | 11.70% |
| 2003-03-31 | $0.03B | $0.22B | 12.79% |
| 2002-12-31 | $0.03B | $0.22B | 14.38% |
| 2002-09-30 | $0.02B | $0.21B | 10.38% |
| 2002-06-30 | $0.03B | $0.22B | 11.26% |
| 2002-03-31 | $0.03B | $0.24B | 12.31% |
| 2001-12-31 | $0.03B | $0.26B | 12.16% |
| 2001-09-30 | $0.04B | $0.25B | 16.02% |
| 2001-06-30 | $0.01B | $0.24B | 5.23% |
| 2001-03-31 | $0.01B | $0.22B | 3.43% |
| 2000-12-31 | $0.00B | $0.20B | 0.50% |
| 2000-09-30 | $0.00B | $0.19B | -0.49% |
| 2000-06-30 | $0.02B | $0.21B | 9.51% |
| 2000-03-31 | $0.02B | $0.21B | 9.43% |
| 1999-12-31 | $0.03B | $0.21B | 11.57% |
| 1999-09-30 | $0.02B | $0.21B | 10.53% |
| 1999-06-30 | $0.02B | $0.22B | 10.10% |
| 1999-03-31 | $0.02B | $0.22B | 9.84% |
| 1998-12-31 | $-0.01B | $0.22B | -4.35% |
| 1998-09-30 | $-0.03B | $0.21B | -12.62% |
| 1998-06-30 | $-0.03B | $0.20B | -12.80% |
| 1998-03-31 | $-0.03B | $0.20B | -11.91% |
| 1997-12-31 | $0.01B | $0.22B | 2.66% |
| 1997-09-30 | $0.03B | $0.23B | 10.91% |
| 1997-06-30 | $0.03B | $0.23B | 13.03% |
| 1997-03-31 | $0.03B | $0.23B | 14.36% |
| 1996-12-31 | $0.03B | $0.23B | 14.93% |
| 1996-09-30 | $0.04B | $0.24B | 16.13% |
| 1996-06-30 | $0.04B | $0.23B | 16.67% |
| 1996-03-31 | $0.04B | $0.22B | 17.22% |
| 1995-12-31 | $0.04B | $0.22B | 17.73% |
| 1995-09-30 | $0.04B | $0.21B | 17.86% |
| 1995-06-30 | $0.04B | $0.20B | 18.47% |
| 1995-03-31 | $0.03B | $0.19B | 18.60% |
| 1994-12-31 | $0.03B | $0.19B | 18.88% |
| 1994-09-30 | $0.03B | $0.18B | 19.94% |
| 1994-06-30 | $0.03B | $0.17B | 20.48% |
| 1994-03-31 | $0.03B | $0.16B | 21.12% |
| 1993-12-31 | $0.03B | $0.15B | 21.70% |
| 1993-09-30 | $0.03B | $0.14B | 22.35% |
| 1993-06-30 | $0.03B | $0.13B | 22.22% |
| 1993-03-31 | $0.03B | $0.13B | 22.08% |
| 1992-12-31 | $0.02B | $0.12B | 23.02% |
| 1992-09-30 | $0.02B | $0.11B | 22.98% |
| 1992-06-30 | $0.02B | $0.10B | 22.92% |
| 1992-03-31 | $0.02B | $0.09B | 23.60% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.778B | $1.361B |
| Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $192.719B | 21.52 |
| EssilorLuxottica (ESLOY) | France | $140.970B | 0.00 |
| Stryker (SYK) | United States | $137.019B | 26.29 |
| Medtronic (MDT) | Ireland | $131.919B | 18.28 |
| Boston Scientific (BSX) | United States | $113.066B | 25.01 |
| Medline (MDLN) | United States | $62.139B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.969B | 0.00 |
| ResMed (RMD) | United States | $39.571B | 26.42 |
| GE HealthCare Technologies (GEHC) | United States | $36.756B | 17.61 |
| Agilent Technologies (A) | United States | $36.736B | 23.22 |
| Koninklijke Philips (PHG) | Netherlands | $28.368B | 18.53 |
| Terumo (TRUMY) | Japan | $19.441B | 21.97 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.819B | 11.11 |
| Insulet (PODD) | United States | $17.019B | 52.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.739B | 0.00 |
| Baxter (BAX) | United States | $11.170B | 9.02 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.133B | 29.24 |
| Demant (WILYY) | Denmark | $6.521B | 0.00 |
| Envista Holdings (NVST) | United States | $4.785B | 24.25 |
| Lantheus Holdings (LNTH) | United States | $4.303B | 13.11 |
| BillionToOne (BLLN) | United States | $4.147B | 0.00 |
| ICU Medical (ICUI) | United States | $3.806B | 24.16 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.189B | 14.81 |
| Neogen (NEOG) | United States | $2.349B | 51.43 |
| Phibro Animal Health (PAHC) | United States | $2.151B | 18.95 |
| Perrigo (PRGO) | Ireland | $2.015B | 5.05 |
| LeMaitre Vascular (LMAT) | United States | $1.983B | 39.92 |
| QuidelOrtho (QDEL) | United States | $1.977B | 12.71 |
| AtriCure (ATRC) | United States | $1.845B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.622B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.486B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.475B | 64.64 |
| AdaptHealth (AHCO) | United States | $1.442B | 20.88 |
| Capricor Therapeutics (CAPR) | United States | $1.130B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.080B | 320.43 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.021B | 0.00 |
| InMode (INMD) | Israel | $0.953B | 10.77 |
| Tilray Brands (TLRY) | Canada | $0.883B | 0.00 |
| Valneva SE (VALN) | France | $0.817B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.803B | 0.00 |
| Omeros (OMER) | United States | $0.796B | 0.00 |
| CeriBell (CBLL) | United States | $0.747B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.587B | 15.91 |
| Verano Holdings (VRNO) | United States | $0.454B | 0.00 |
| Brainsway (BWAY) | Israel | $0.427B | 72.60 |
| Cerus (CERS) | United States | $0.423B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.405B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.377B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.328B | 26.18 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Evolus (EOLS) | United States | $0.292B | 0.00 |
| Quanterix (QTRX) | United States | $0.284B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.237B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.222B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.208B | 0.00 |
| Organigram Global (OGI) | Canada | $0.207B | 0.00 |
| High Tide (HITI) | Canada | $0.207B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.197B | 17.71 |
| Aurora Cannabis (ACB) | Canada | $0.197B | 58.00 |
| OraSure Technologies (OSUR) | United States | $0.194B | 0.00 |
| Accendra Health (ACH) | United States | $0.185B | 1.85 |
| Sanara MedTech (SMTI) | United States | $0.180B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.179B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.144B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.136B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.72 |
| MacroGenics (MGNX) | United States | $0.115B | 0.00 |
| Biote (BTMD) | United States | $0.102B | 4.46 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Exagen (XGN) | United States | $0.080B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 24.00 |
| Sharps Technology (STSS) | United States | $0.048B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.042B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 29.77 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.033B | 16.63 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| ZeroStack (ZSTK) | United States | $0.010B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |